IP Library › Assignment 051355/0280
Patent Assignment
Reel/Frame 051355/0280

Security Interest

Recorded: 2019-12-23 Pages: 8
Assignor
SAREPTA THERAPEUTICS, INC.
Executed: 2019-12-20
Assignee
BIOPHARMA CREDIT PLC
51 NEW NORTH ROAD, C/O BEAUFORT HOUSE, EXETER EX4 4EP, UNITED KINGDOM
Covered Properties (16)
Compositions for Treating Muscular Dystrophy
Patent: 9,506,058 →
Application: 14/214,567 →
Publication: US 2014/0315862
Splice-Region Antisense Composition and Method
Patent: 9,416,361 →
Application: 14/535,098 →
Publication: US 2015/0232839
Compositions for Treating Muscular Dystrophy
Application: 15/359,152 →
Publication: US 2017/0283799
Exon Skipping Compositions for Treating Muscular Dystrophy
Application: 15/420,823 →
Publication: US 2017/0369875
Compositions for Treating Muscular Dystrophy
Application: 15/604,335 →
Publication: US 2018/0105811
Methods for Treating Muscular Dystrophy
Application: 15/763,417 →
Publication: US 2019/0054113
Multiple Exon Skipping Compositions for Dmd
Application: 16/146,328 →
Publication: US 2019/0284556
Multiple Exon Skipping Compositions for Dmd
Application: 16/243,926 →
Publication: US 2019/0127738
Processes for Preparing Phosphorodiamidate Morpholino Oligomers
Application: 16/302,443 →
Publication: US 2019/0276480
Pharmaceutical Compositions Comprising Eteplirsen
Application: 16/302,484 →
Publication: US 2019/0275072
Processes for Preparing Phosphorodiamidate Morpholino Oligomers
Application: 16/302,529 →
Publication: US 2019/0292208
Exon Skipping Compositions for Treating Muscular Dystrophy
Application: 16/358,169 →
Publication: US 2020/0040336
Compositions for Treating Muscular Dystrophy
Application: 16/422,241 →
Publication: US 2019/0359982
Compositions for Treating Muscular Dystrophy
Application: 16/434,799 →
Publication: US 2020/0040337
Methods for Treating Muscular Dystrophy
Application: 62/863,456 →
Phosphorodiamidate Morpholino Oligomer Pharmaceutical Compositions
Application: 62/881,996 →
Related Assignments (19)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 1, 2014
From: KAYE, EDWARD M
To: SAREPTA THERAPEUTICS, INC.
Reel/Frame 033443/0095 →
Assignment of Assignor's Interest Feb 27, 2017
From: KAYE, EDWARD M.
To: SAREPTA THERAPEUTICS, INC.
Reel/Frame 041386/0077 →
Assignment of Assignor's Interest Feb 27, 2017
From: FRANK, DIANE ELIZABETH; BESTWICK, RICHARD K.
To: SAREPTA THERAPEUTICS, INC.
Reel/Frame 041386/0973 →
Assignment of Assignor's Interest Jun 13, 2017
From: KAYE, EDWARD M.
To: SAREPTA THERAPEUTICS, INC.
Reel/Frame 042694/0457 →
Change of Name Jul 25, 2017
From: AVI BIOPHARMA, INC.
To: SAREPTA THERAPEUTICS, INC.
Reel/Frame 043327/0661 →
Assignment of Assignor's Interest Jul 25, 2017
From: IVERSEN, PATRICK L.; HUDZIAK, ROBERT
To: AVI BIOPHARMA, INC.
Reel/Frame 043093/0672 →
Assignment of Assignor's Interest Apr 11, 2018
From: KAYE, EDWARD M.
To: SAREPTA THERAPEUTICS, INC.
Reel/Frame 045505/0723 →
Assignment of Assignor's Interest Apr 11, 2018
From: KAYE, EDWARD M.
To: SAREPTA THERAPEUTICS, INC.
Reel/Frame 045505/0716 →
Assignment of Assignor's Interest Apr 11, 2018
From: KAYE, EDWARD M.
To: SAREPTA THERAPEUTICS, INC.
Reel/Frame 045505/0729 →
Assignment of Assignor's Interest Apr 11, 2018
From: KAYE, EDWARD M.
To: SAREPTA THERAPEUTICS, INC.
Reel/Frame 045909/0957 →
Assignment of Assignor's Interest Jun 13, 2019
From: HOLT, THOMAS
To: SAREPTA THERAPEUTICS, INC.
Reel/Frame 049460/0036 →
Assignment of Assignor's Interest Jul 19, 2019
From: O'NEILL, GILMORE
To: SAREPTA THERAPEUTICS, INC.
Reel/Frame 049797/0881 →
Assignment of Assignor's Interest Oct 17, 2019
From: HOLT, THOMAS
To: SAREPTA THERAPEUTICS, INC.
Reel/Frame 050744/0679 →
Assignment of Assignor's Interest Dec 20, 2019
From: CAI, BAOZHONG; MARTINI, MITCHELL; THOMAS, KATIE; SHIMABUKU, ROSS
To: SAREPTA THERAPEUTICS, INC.
Reel/Frame 051346/0036 →
Assignment of Assignor's Interest Jan 2, 2020
From: CAI, BAOZHONG; MARTINI, MITCHELL; SHIMABUKU, ROSS; THOMAS, KATIE
To: SAREPTA THERAPEUTICS, INC.
Reel/Frame 051402/0903 →
Corrective Assignment to Correct the Typographical Error App. No 62/869,456 Should Be Corrected as 62/863,456 Previously Recorded at Reel: 051355 Frame: 0280. Assignor(S) Hereby Confirms the Assignment. Jan 9, 2020
From: SAREPTA THERAPEUTICS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 051554/0339 →
Assignment of Assignor's Interest Feb 2, 2021
From: BESTWICK, RICHARD K.; FRANK, DIANE ELIZABETH
To: SAREPTA THERAPEUTICS, INC.
Reel/Frame 055111/0650 →
Release of Security Interest Sep 16, 2022
From: BIOPHARMA CREDIT PLC
To: SAREPTA THERAPEUTICS, INC.
Reel/Frame 061120/0886 →
Security Interest May 7, 2025
From: SAREPTA THERAPEUTICS, INC.
To: JPMORGAN CHASE BANK, N.A. AS ADMINISTRATIVE AGENT
Reel/Frame 071218/0445 →